0001104659-21-005570.txt : 20210119
0001104659-21-005570.hdr.sgml : 20210119
20210119215053
ACCESSION NUMBER: 0001104659-21-005570
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210114
FILED AS OF DATE: 20210119
DATE AS OF CHANGE: 20210119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Esposito Pamela
CENTRAL INDEX KEY: 0001744425
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38596
FILM NUMBER: 21537304
MAIL ADDRESS:
STREET 1: C/O REPLIMUNE GROUP, INC.
STREET 2: 18 COMMERCE WAY
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Replimune Group, Inc.
CENTRAL INDEX KEY: 0001737953
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 822082553
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 500 UNICORN PARK
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: (781) 222-9600
MAIL ADDRESS:
STREET 1: 500 UNICORN PARK
CITY: WOBURN
STATE: MA
ZIP: 01801
4
1
tm213368-5_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-01-14
0
0001737953
Replimune Group, Inc.
REPL
0001744425
Esposito Pamela
C/O REPLIMUNE GROUP, INC.
18 COMMERCE WAY
WOBURN
MA
01801
0
1
0
0
Chief Business Officer
Common Stock
2021-01-14
4
M
0
20000
1.01
A
195994
D
Common Stock
2021-01-14
4
S
0
20000
45.02
D
175994
D
Common Stock
2021-01-15
4
M
0
29273
1.01
A
205267
D
Common Stock
2021-01-15
4
S
0
29273
43.58
D
175994
D
Common Stock
2021-01-19
4
M
0
5727
1.01
A
181721
D
Common Stock
2021-01-19
4
S
0
600
43.24
D
181121
D
Common Stock
2021-01-19
4
S
0
5127
42.38
D
175994
D
Employee Stock Option (right to buy)
1.01
2021-01-14
4
M
0
20000
0
D
2025-11-01
Common Stock
20000
108203
D
Employee Stock Option (right to buy)
1.01
2021-01-15
4
M
0
29273
0
D
2025-11-01
Common Stock
29273
78930
D
Employee Stock Option (right to buy)
1.01
2021-01-19
4
M
0
5727
0
D
2025-11-01
Common Stock
5727
73203
D
The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 14, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.88 to $43.86. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.76. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Following the sales reported on this Form 4, the reporting person continues to beneficially own 175,994 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 497,852 shares of the Issuer's common stock, 458,852 of which are exercisable as of the date hereof.
The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof.
/s/ Jean Franchi, attorney-in-fact
2021-01-19